Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

In this interview, News Medical speaks with Dr Bryony Henderson, Medical Director for the UK and US at MedExpress, about the evolving role of GLP‑1 agonists in obesity care and the future of metabolic ...

It's no secret that starting a GLP-1 weight-loss medication is as much an emotional journey as it is a physical one. From navigating inevitable ups and downs to quashing cravings and finding the ...

Whether you choose a daily pill or a weekly injection, GLP-1 medications work by mimicking GLP-1, a natural hormone your body releases after a meal. It helps control appetite, digestion, and blood ...

The word microdosing might make you think of LSD and magic mushrooms, but the term has gained a totally new meaning in the Age of Ozempic. Microdosing—essentially, taking a smaller dose of something ...

Risks for kidney failure and major cardiovascular events between three GLP-1 receptor agonists were similar among veterans with diabetes. Mortality risk and certain adverse events differed between the ...

If you live with obesity or type 2 diabetes, your doctor may have talked to you about GIP/GLP-1 agonist medications, such as tirzepatide (Mounjaro or Zepbound), which may help you lose weight. And ...

GLP-1RAs improved RA disease activity, pain scores, weight, cholesterol, and HbA1c levels in patients with a BMI ≥27. Nearly one-third of patients discontinued GLP-1RA therapy due to gastrointestinal ...

SAN DIEGO — New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings ...

If you miss a dose of GLP-1, you may be able to take it right away or wait until your next scheduled dose. It depends on the medication you take and how many doses you’ve missed. Glucagon-like peptide ...